본문으로 바로가기
현재 위치:
Home
진료과
외과(장기이식센터)
홍근
관심콘텐츠
프린트

의료진 소개

진료과 의료진
홍근 의사

홍근 교수


장기이식센터장 외과(장기이식센터), 장기이식센터 관심의료진 등록

전문 진료 분야

간이식, 간암 및 간질환수술

진료 일정

진료예약 간편 예약 고맙습니다

학력 및 경력사항

학력사항

  • 서울대학교 의과대학 의학과 외과학 박사 과정
  • 서울대학교 의과대학 의학과 외과학 석사
  • 서울대학교 의과대학 졸업

교육 및 연구경력

  • 서울대학교병원 장기이식센터 진료교수
  • 이대목동병원 장기이식센터장
  • 서울대학교병원 간담췌외과, 간절제 및 간이식 전임의 수료
  • 서울대학교병원 외과 전공의 수료
  • 서울대학교병원 인턴 수료

기타 학술 관련 경력

  • 2012  | 세계간이식학회 ILTS Travel grant award
  • 2011  | 한국간담췌외과학회 추계학술대회 학술발표상
  • 세계간이식학회
  • 대한간학회, 대한간암연구학회
  • 한국간담췌외과학회
  • 대한이식학회, 대한간이식연구회

논문

  •  Non-Renal Risk Factors for Chronic Kidney Disease in Liver Recipients with Functionally Intact Kidneys at 1 Month.  JOURNAL OF CLINICAL MEDICINE. 2022, v.11 no.14, 4203. 
  •  Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study.  Journal of Clinical Medicine. 2022, v.11 no.10, 2806. 
  •  A comparative study of postoperative outcomes between minimally invasive living donor hepatectomy and open living donor hepatectomy: The Korean organ transplantation registry.  SURGERY, 2021. v.170 no.1, 271-276. 
  •  Efficacy and safety of a switch from twice- daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients.  Korean Journal of Transplantation. 2021, v.35 no.3, 168-176. 
  •  Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.  CLINICAL AND MOLECULAR HEPATOLOGY. 2021, v.27 no.3, 451-462. 
  •  Lymphaticovenular Anastomosis for Treatment of Lymphedema Developed After Liver Transplantation: A Case Report.  TRANSPLANTATION PROCEEDINGS. 2020, v.52 no.9, 2773-2777. 
  •  New-onset diabetes after adult liver transplantation in the Korean Organ Transplantation Registry (KOTRY) study.  HEPATOBILIARY SURGERY AND NUTRITION. 2020, v.9 no.4, 425-. 
  •  Cycling of Dexmedetomidine May Prevent Delirium After Liver Transplantation.  TRANSPLANTATION PROCEEDINGS. 2018, v.50 no.4, 1080-1082. 
  •  Donor Safety in Living Donor Liver Transplantation: The Korean Organ Transplantation Registry Study.  LIVER TRANSPLANTATION. 2017, v.23 no.8, 999-1006. 
  •  Alpha-fetoprotein and F-18-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.  JOURNAL OF HEPATOLOGY. 2016, v.64 no.4, 852-859. 
  •  Non-Surgical Management of Portal Vein Shunt and Thrombocytopenia After Liver Transplantation (Case).  TRANSPLANTATION. 2016, v.100, S204-S204. 
  •  Preoperative alpha-fetoprotein and 18F-FDG PET predict tumor recurrence better than Milan criteria in living donor liver transplantation.  Journal of Hepatology. 2016, 30 NOV 2015. 
  •  The safety and risk factors of major hepatobiliary pancreatic surgery in patients older than 80 years.  Annals of Surgical Treatment and Research. 2016, v.91 no.6, 288-294. 
  •  The safety and risk factors of major hepatobiliary pancreatic surgery in patients older than 80 years.  대한외과학회지. 2016, v.91 no.6, 288. 
  •  Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation.  INTERNATIONAL SURGERY. 2015, v.100 no.3, 524-530. 
  •  EXCELLENT OUTCOME OF THE NEW LIVER TRANSPLANTATION CENTER.  TRANSPLANT INTERNATIONAL. 2015, v.28, 625-625. 
  •  Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging.  ANNALS OF SURGICAL TREATMENT AND RESEARCH. 2015, v.89 no.1, 37-42. 
  •  Identification of a safe and adequate division point of the left-sided bile duct with magnetic resonance cholangiography during donor left lateral sectionectomy.  SURGERY. 2015, v.157 no.4, 785-791. 
  •  Long-term Outcome of Primary Closure After Laparoscopic Common Bile Duct Exploration Combined With Choledochoscopy.  SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES. 2015, v.25 no.3, 250-253. 
  •  Preparation for high altitude expedition and changes in cardiopulmonary and biochemical laboratory parameters with ascent to high altitude in transplant patients and live donors.  Clinical Transplantation. 2015, v.29 no.11, 1013-1020. 
  •  RECONSTRUCTION OF THE REPLACED RIGHT HEPATIC ARTERY WITH AORTIC PATCH AT THE BACK TABLE IN THE DECEASED DONOR LIVER TRANSPLANTATION (CASE).  TRANSPLANT INTERNATIONAL. 2015, v.28, 529-529. 
  •  Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: A case report.  PEDIATRIC TRANSPLANTATION. 2014, v.18 no.7, E240-E245. 
  •  Histologically proven non- alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.  CLINICAL TRANSPLANTATION. 2014, v.28 no.5, 521-529. 
  •  Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases.  ANNALS OF SURGICAL TREATMENT AND RESEARCH. 2014, v.87 no.1, 14-21. 
  •  Living-Donor Liver Transplantation Associated With Higher Incidence of Hepatocellular Carcinoma Recurrence Than Deceased-Donor Liver Transplantation.  TRANSPLANTATION. 2014, v.97 no.1, 71-77. 
  •  Long-Term Outcome of Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma: A Case-Controlled Study with Propensity Score Matching.  SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2014, v.28 no.3, 950-960. 
  •  Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma.  JOURNAL OF KOREAN MEDICAL SCIENCE. 2014, v.29 no.10, 1360-1366. 
  •  Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume.  JOURNAL OF KOREAN MEDICAL SCIENCE. 2014, v.29 no.5, 640-647. 
  •  Usefulness of Preoperative C-Reactive Protein and Alpha-Fetoprotein Levels for Prognostication of Patients with Hepatocellular Carcinoma after Living Donor Liver Transplantation.  HEPATO-GASTROENTEROLOGY. 2014, v.61 no.136, 2353-2358.